(Press-News.org) PHILADELPHIA – Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.
"Our study is quite significant because it provides an objective way to understand pain and why different individuals have different pain tolerance levels," said study author Tobore Onojjighofia, MD, MPH, with Proove Biosciences and a member of the American Academy of Neurology. "Identifying whether a person has these four genes could help doctors better understand a patient's perception of pain."
Researchers evaluated 2,721 people diagnosed with chronic pain for certain genes. Participants were taking prescription opioid pain medications. The genes involved were COMT, DRD2, DRD1 and OPRK1. The participants also rated their perception of pain on a scale from zero to 10. People who rated their pain as zero were not included in the study. Low pain perception was defined as a score of one, two or three; moderate pain perception was a score of four, five or six; and high pain perception was a score of seven, eight, nine or 10.
Nine percent of the participants had low pain perception, 46 percent had moderate pain perception and 45 percent had high pain perception.
The researchers found that the DRD1 gene variant was 33 percent more prevalent in the low pain group than in the high pain group. Among people with a moderate pain perception, the COMT and OPRK variants were 25 percent and 19 percent more often found than in those with a high pain perception. The DRD2 variant was 25 percent more common among those with a high pain perception compared to people with moderate pain.
"Chronic pain can affect every other part of life," said Onojjighofia. "Finding genes that may be play a role in pain perception could provide a target for developing new therapies and help physicians better understand their patients' perceptions of pain."
INFORMATION:
The study was supported by Proove Biosciences, Inc.
Learn more about chronic pain at http://www.aan.com/patients.
The American Academy of Neurology, an association of more than 27,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease,
stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Editor's Note:
Dr. Onojjighofia will present his findings at 7:30 a.m. on Wednesday, April 30, 2014, in Hall E of the Pennsylvania Convention Center in Philadelphia.
Dr. Onojjighofia is available for advance interviews as well. Please contact Rachel Seroka, rseroka@aan.com, to schedule an advance interview.
To access Non-Emerging Science abstracts to be presented at the 2014 AAN Annual Meeting, visit https://www.aan.com/conferences/2014-annual-meeting/browse-abstracts. Emerging Science abstracts are embargoed until 12:01a.m., ET, Friday, April 25, 2014, unless otherwise noted by the Academy's Media and Public Relations Department.
Media Contacts:
Rachel Seroka, rseroka@aan.com, (612) 928-6129
Michelle Uher, muher@aan.com, (612) 928-6120
Low tolerance for pain? The reason may be in your genes
2014-04-20
ELSE PRESS RELEASES FROM THIS DATE:
'Chaperone' compounds offer new approach to Alzheimer's treatment
2014-04-20
NEW YORK, NY (April 20, 2014) — A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer's.
Using computer-based virtual screening, ...
Bulletproof nuclei? Stem cells exhibit unusual absorption property
2014-04-20
Stem cells – the body's master cells – demonstrate a bizarre property never before seen at a cellular level, according to a study published today from scientists at the University of Cambridge. The property – known as auxeticity – is one which may have application as wide-ranging as soundproofing, super-absorbent sponges and bulletproof vests.
Most materials when stretched will contract. For example, if one pulls on an elastic band, the elastic itself will get thinner. The opposite is also true: squeeze a material and it will expand – for example, if one squeezes a tennis ...
Computational method dramatically speeds up estimates of gene expression
2014-04-20
PITTSBURGH—With gene expression analysis growing in importance for both basic researchers and medical practitioners, researchers at Carnegie Mellon University and the University of Maryland have developed a new computational method that dramatically speeds up estimates of gene activity from RNA sequencing (RNA-seq) data.
With the new method, dubbed Sailfish after the famously speedy fish, estimates of gene expression that previously took many hours can be completed in a few minutes, with accuracy that equals or exceeds previous methods. The researchers' report on their ...
Cancer stem cells linked to drug resistance
2014-04-20
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a molecule, or biomarker, called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem cell-like properties of cancer cells.
The findings, published in the April 20, 2014 online issue of Nature Cell Biology, may point to new therapeutic opportunities for reversing drug resistance in a range ...
Study of gut microbes, antibiotics: Clues to improving immunity in premature infants
2014-04-20
Mothers give a newborn baby a gift of germs—germs that help to kick-start the infant's immune system. But antibiotics, used to fend off infection, may paradoxically interrupt a newborn's own immune responses, leaving already-vulnerable premature babies more susceptible to dangerous pathogens.
A new animal study by neonatology researchers at The Children's Hospital of Philadelphia (CHOP) sheds light on immunology in newborns by revealing how gut microbes play a crucial role in fostering the rapid production of infection-fighting white blood cells, called granulocytes.
"At ...
Dana-Farber researchers uncover link between Down syndrome and leukemia
2014-04-20
BOSTON –Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.
In a study posted online today by the journal Nature Genetics, the researchers track the genetic chain of events that links a chromosomal abnormality in Down syndrome to the cellular havoc that occurs in ALL. Their findings are relevant not only to people with ...
Stanford scientists identify source of most cases of invasive bladder cancer
2014-04-20
STANFORD, Calif. — A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine.
Their study, conducted in mice, is the first to pinpoint the normal cell type that can give rise to invasive bladder cancers. It's also the first to show that most bladder cancers and their associated precancerous lesions arise from just one cell, and explains why many human bladder cancers recur after therapy.
"We've learned that, at an intermediate stage during cancer ...
Study casts doubt on climate benefit of biofuels from corn residue
2014-04-20
Lincoln, Neb., April 20, 2014 -- Using corn crop residue to make ethanol and other biofuels reduces soil carbon and can generate more greenhouse gases than gasoline, according to a study published today in the journal Nature Climate Change.
The findings by a University of Nebraska-Lincoln team of researchers cast doubt on whether corn residue can be used to meet federal mandates to ramp up ethanol production and reduce greenhouse gas emissions.
Corn stover -- the stalks, leaves and cobs in cornfields after harvest -- has been considered a ready resource for cellulosic ...
Score Promotions Opens Florida Office to Better Serve Promotional Product Needs of U.S. Clients
2014-04-20
The Fort Lauderdale, Florida office represents a more concerted push into the U.S. market following the success of the Toronto office and continued growth worldwide", said Tom Greenberg, President.
With the opening of a new office in Florida, promotional product company Score Promotions will be able to offer a number of services and logistical upgrades to its U.S. clients. The expansion comes as the Company celebrates 15 years in business, during which time it has become one of the leading promotional products suppliers in Canada.
Score Promotions continually seeks ...
Scores.fm Gives Sports Fans a Voice
2014-04-20
One thing most sports fans have in common is that they have an opinion about the game and they are willing to share that opinion with anyone who will listen. The problem is finding those like-minded listeners who will appreciate, and even discuss, that opinion. Now a young sports media company is stepping up to provide that audience for anyone who wishes to share their thoughts with the masses.
Scores.fm is an online sports magazine and sports radio station that has gained international recognition. Operated by Scores Media Group, the publishing and broadcasting venture ...